News 12 May 2022 Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Conference admin
News 02 May 2022 New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device admin
News 06 Apr 2022 New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor’s Blood Volume Diagnostic (BVA-100®) for Improving Worsening Heart Failure admin
News 23 Mar 2022 Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference admin
News 01 Mar 2022 Daxor Corporation CEO & President Michael Feldschuh Provides Corporate Update in Letter to Shareholders admin
News 01 Mar 2022 Daxor Corporation Announces $1.35 Per Share NAV Increase and Files Annual Report for Fiscal 2021 admin
News 17 Feb 2022 Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Assessment of Heart Failure admin
